Cantor Fitzgerald Maintains Overweight on GW Pharmaceuticals, Lowers Price Target to $174

Cantor Fitzgerald maintains GW Pharmaceuticals (NASDAQ:GWPH) with a Overweight and lowers the price target from $229 to $174.

Benzinga · 11/06/2019 11:56

Cantor Fitzgerald maintains GW Pharmaceuticals (NASDAQ:GWPH) with a Overweight and lowers the price target from $229 to $174.